Arkolith/Insider Trading/AUPH/Form 4

Keenan Greg

Chief Medical OfficerAurinia Pharmaceuticals Inc. (AUPH) · full profile →Form 4 · filed Mar 4, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$98K
Net Open-Market Flow
-$98K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2025Sell(S)12K$8.00$98K162K
Feb 28, 2025Grant(A)63K—$0174K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 28, 2025Grant(A)96K—$096K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001600620-25-000022) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML